Molecular Insight Enters Ch. 11 With $45M Finance Plan
Cancer treatment research company Molecular Insight Pharmaceuticals Inc. has filed for Chapter 11 with a restructuring plan that would see Savitr Capital LLC provide $45 million in financing, following a failure...To view the full article, register now.
Already a subscriber? Click here to view full article